MDL 100748

Overview

MDL 100748 is an NMDA receptor glycine site antagonist. MDL 100748 modulates NMDA receptor function by acting at the strychnine-insensitive glycine site, which is required for NMDA receptor activation alongside glutamate. MDL 100748 decreases response rates in operant conditioning sessions in phencyclidin (PCP)-trained rats. MDL 100748 can be used for reserach on dementias and schizophrenia.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Others | Products > Disease Areas > Schizophrenia | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Research Areas > Others | Products > Signaling Pathways > iGluR

Product Information

• Catalog No.: HY-182479
• CAS No.: 130613-18-2
• Molecular Formula: C12H8Cl2N2O4
• Molecular Weight: 315.11
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source